BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10779423)

  • 1. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
    Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
    Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
    Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
    Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles.
    Samakoglu S; Bohl D; Heard JM
    Mol Ther; 2002 Dec; 6(6):793-803. PubMed ID: 12498775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia.
    Villeval JL; Rouyer-Fessard P; Blumenfeld N; Henri A; Vainchenker W; Beuzard Y
    Blood; 1994 Aug; 84(3):928-33. PubMed ID: 8043875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
    Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
    Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
    Beauchemin H; Blouin MJ; Trudel M
    J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA.
    Payen E; Bettan M; Rouyer-Fessard P; Beuzard Y; Scherman D
    Exp Hematol; 2001 Mar; 29(3):295-300. PubMed ID: 11274756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
    Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
    Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
    Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
    Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S; May C; Chadburn A; Rivière I; Sadelain M
    Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
    Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
    Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective erythropoiesis and HbF reactivation induced by kit ligand in beta-thalassemia.
    Gabbianelli M; Morsilli O; Massa A; Pasquini L; Cianciulli P; Testa U; Peschle C
    Blood; 2008 Jan; 111(1):421-9. PubMed ID: 17951528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.
    Srinoun K; Svasti S; Chumworathayee W; Vadolas J; Vattanaviboon P; Fucharoen S; Winichagoon P
    Haematologica; 2009 Sep; 94(9):1211-9. PubMed ID: 19608680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients.
    Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S
    PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis
    Drakopoulou E; Georgomanoli M; Lederer CW; Kleanthous M; Costa C; Bernadin O; Cosset FL; Voskaridou E; Verhoeyen E; Papanikolaou E; Anagnou NP
    Hum Gene Ther; 2019 May; 30(5):601-617. PubMed ID: 30324804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of mouse beta-thalassemia by recombinant human erythropoietin.
    Leroy-Viard K; Rouyer-Fessard P; Beuzard Y
    Blood; 1991 Sep; 78(6):1596-602. PubMed ID: 1884025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
    Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.
    Liang R; Lin M; Menon V; Qiu J; Menon A; Breda L; Arif T; Rivella S; Ghaffari S
    Blood Adv; 2023 Nov; 7(22):6873-6885. PubMed ID: 37672319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective erythroid replacement in murine beta-thalassemia using fetal hematopoietic stem cells.
    Bethel CA; Murugesh D; Harrison MR; Mohandas N; Rubin EM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10120-4. PubMed ID: 7980734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.